Clinical Policy: Finerenone (Kerendia)
Defines the clinical policy governance and use conditions for finerenone (Kerendia) for Centene members; outlines provider responsibilities and precedence of state Medicaid provisions where applicable.
No material clinical or coverage changes in this revision.
Coverage Criteria
For members enrolled in Medicaid, state Medicaid coverage provisions take precedence over the coverage provisions in this clinical policy when there is a conflict. Refer to the applicable state Medicaid manual for specific coverage provisions that apply to Medicaid members.
Provider Actions and Responsibilities
Medicaid precedence
For Medicaid members, when state Medicaid coverage provisions conflict with the coverage provisions in this clinical policy, state Medicaid coverage provisions take precedence. Refer to the applicable state Medicaid manual for specific coverage rules and requirements.
Clinical judgment
It is not the intent of this clinical policy to dictate how providers practice medicine. Providers are expected to exercise independent professional medical judgment in providing the most appropriate care for members and remain solely responsible for medical advice and treatment decisions.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.